AM22-08-O - AM22-08-O: (On-Demand) Plenary Abstract Session (Enduring)

Nov 7, 2022 5:00pm ‐ Nov 7, 2022 6:00pm

Expiration Date: Dec 31, 2024

Credits: None available.

Overview
CE Information

Oral abstract session on Plenary Abstracts.

Learning Objectives:

Understand the impact of pathogen reduction on platelet transfusion safety.
Evaluate the risk of transfusion-transmitted SARS-CoV-2.
Examine the mechanism of alloantibody production after platelet transfusions.
Investigate the use of platelets as a method deliver therapeutic proteins.
Understand the mechanism underlying the Helgeson phenotype, the serological null phenotype of the Knops blood group system.

Speaker(s):

Adèle Couvidou, EFS GRAND EST
Rachael Jackman, PhD, Vitalant Research Institute
Scott Koepsell, MD PhD, University of Nebraska Medical Center
Jerry Leung, Biochemistry and Molecular Biology, The University of British Columbia
John Pitman, Scientific and Medical Affairs, Cerus Corporation
Ping Chun Wu, MSc, Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University

Moderator(s):

Melissa Cushing, MD, Executive Vice Chair, Weill Cornell Medicine Department of Pathology and Laboratory Medicine

Tags:

collections processing and storage Biotherapies Cellular Therapies and Immunotherapies

By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.

Credits Available

AM22-08-O: (On-Demand) Plenary Abstract Session (Enduring) Evaluation

1.00 - General Continuing Education (GEN)
1.00 - Florida Lab Personnel (FLP)
1.00 - California Nurse (CN)
1.00 - California Lab Personnel (CLP)